Skip to main content
Log in

Polymorphisms of mtDNA in the D-loop region moderate the associations of BMI with HOMA-IR and HOMA-β among women with polycystic ovary syndrome: a cross-sectional study

  • Genetics
  • Published:
Journal of Assisted Reproduction and Genetics Aims and scope Submit manuscript

A Correction to this article was published on 17 July 2023

This article has been updated

Abstract

Purpose

Polycystic ovary syndrome (PCOS) is one of the leading causes of infertility in women of childbearing age, and many patients with PCOS have obesity and insulin resistance (IR). Although obesity is related to an increased risk of IR, in clinical practice, PCOS patients exhibit different effects on improving insulin sensitivity after weight loss. Therefore, in the present study, we aimed to examine the moderating effect of polymorphisms of mtDNA in the D-loop region on the associations of body mass index (BMI) with the homeostasis model assessment of insulin resistance index (HOMA-IR) and pancreatic β cell function index (HOMA-β) among women with PCOS.

Methods

Based on a cross-sectional study, women with PCOS were recruited from the Reproductive Center of the First Affiliated Hospital of Anhui Medical University from 2015 to 2018. A total of 520 women who were diagnosed with PCOS based on the revised 2003 Rotterdam criteria were included in the study. Peripheral blood was collected from these patients, followed by DNA extraction, PCR amplification, and sequencing at baseline. HOMA-IR and HOMA-β were calculated according to blood glucose-related indices. Moderating effect models were performed with BMI as an independent variable, polymorphisms of mtDNA in the D-loop region as moderators, and ln (HOMA-IR) and ln (HOMA-β) as dependent variables. To verify the stability of moderating effect, sensitivity analysis was performed with the quantitative insulin sensitivity check index (QUICKI), fasting plasma glucose/fasting insulin (G/I), and fasting insulin as dependent variables.

Results

BMI was positively associated with ln (HOMA-IR) and ln (HOMA-β) (β = 0.090, p < 0.001; β = 0.059, p < 0.001, respectively), and the relationship between BMI and ln (HOMA-IR) or ln (HOMA-β) was moderated by the polymorphisms of mtDNA in the D-loop region. Compared with the respective wild-type, the variant -type of m.16217 T > C enhanced the association between BMI and HOMA-IR, while the variant-type of m.16316 A > G weakened the association. On the other hand, the variant-type of m.16316 A > G and m.16203 A > G weakened the association between BMI and HOMA-β, respectively. The results of QUICKI and fasting insulin as dependent variables were generally consistent with HOMA-IR, and the results of G/I as dependent variables were generally consistent with HOMA-β.

Conclusion

Polymorphisms of mtDNA in the D-loop region moderate the associations of BMI with HOMA-IR and HOMA-β among women with PCOS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

Data Availability

The authors do not have permission to share data.

Change history

References

  1. Escobar-Morreale HF. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol. 2018;14(5):270–84.

    Article  PubMed  Google Scholar 

  2. Fauser BCJM. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19–25.

  3. McCartney CR, Marshall JC. CLINICAL PRACTICE. Polycystic ovary syndrome. N Engl J Med. 2016;375(1):54–64.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Sagvekar P, Dadachanji R, Patil K, Mukherjee S. Pathomechanisms of polycystic ovary syndrome: multidimensional approaches. Front Biosci (Elite Ed). 2018;10(3):384–422.

    Article  PubMed  Google Scholar 

  5. Patel S. Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy. J Steroid Biochem Mol Biol. 2018;182:27–36.

    Article  CAS  PubMed  Google Scholar 

  6. Marshall JC, Dunaif A. Should all women with PCOS be treated for insulin resistance? Fertil Steril. 2012;97(1):18–22.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Malin SK, Kirwan JP, Sia CL, González F. Pancreatic β-cell dysfunction in polycystic ovary syndrome: role of hyperglycemia-induced nuclear factor-κB activation and systemic inflammation. Am J Physiol Endocrinol Metab. 2015;308(9):E770–7.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Manco M, Castagneto-Gissey L, Arrighi E, Carnicelli A, Brufani C, Luciano R, et al. Insulin dynamics in young women with polycystic ovary syndrome and normal glucose tolerance across categories of body mass index. PLoS One. 2014;9(4):e92995.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Tao T, Li S, Zhao A, Mao X, Liu W. Early impaired β-cell function in Chinese women with polycystic ovary syndrome. Int J Clin Exp Pathol. 2012;5(8):777–86.

    PubMed  PubMed Central  Google Scholar 

  10. Yan C, Duanmu X, Zeng L, Liu B, Song Z (2019) Mitochondrial DNA: distribution, mutations, and elimination. Cells 8(4):379.

  11. Mishra P, Chan DC. Mitochondrial dynamics and inheritance during cell division, development and disease. Nat Rev Mol Cell Biol. 2014;15(10):634–46.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Murri M, Luque-Ramírez M, Insenser M, Ojeda-Ojeda M, Escobar-Morreale HF. Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and meta-analysis. Hum Reprod Update. 2013;19(3):268–88.

    Article  CAS  PubMed  Google Scholar 

  13. Hunter RG, Seligsohn M, Rubin TG, Griffiths BB, Ozdemir Y, Pfaff DW, et al. Stress and corticosteroids regulate rat hippocampal mitochondrial DNA gene expression via the glucocorticoid receptor. Proc Natl Acad Sci USA. 2016;113(32):9099–104.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Ilie IR. Advances in PCOS Pathogenesis and progression-mitochondrial mutations and dysfunction. Adv Clin Chem. 2018;86:127–55.

    Article  CAS  PubMed  Google Scholar 

  15. Skov V, Glintborg D, Knudsen S, Jensen T, Kruse TA, Tan Q, et al. Reduced expression of nuclear-encoded genes involved in mitochondrial oxidative metabolism in skeletal muscle of insulin-resistant women with polycystic ovary syndrome. Diabetes. 2007;56(9):2349–55.

    Article  CAS  PubMed  Google Scholar 

  16. Saeed N, Hamzah IH, Al-Gharrawi SAR. Polycystic ovary syndrome dependency on mtDNA mutation; copy number and its association with insulin resistance. BMC Res Notes. 2019;12(1):455.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Eaaswarkhanth M, Melhem M, Sharma P, Nizam R, Al Madhoun A, Chaubey G, et al. Mitochondrial DNA D-loop sequencing reveals obesity variants in an Arab population. Appl Clin Genet. 2019;12:63–70.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev. 1997;18(6):774–800.

    CAS  PubMed  Google Scholar 

  19. Witchel SF, Oberfield SE, Peña AS. Polycystic ovary syndrome: pathophysiology, presentation, and treatment with emphasis on adolescent girls. J Endocr Soc. 2019;3(8):1545–73.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Lin CA, Liu YP, Chen YC, Yu W, Xiong XJ, Huang HY, et al. Gender-specific and age-specific associations of the homoeostasis model assessment for IR (HOMA-IR) with albuminuria and renal function impairment: a retrospective cross-sectional study in Southeast China. BMJ Open. 2021;11(12):e053649.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Dabravolski SA, Nikiforov NG, Eid AH, Nedosugova LV, Starodubova AV, Popkova TV, et al (2021) Mitochondrial dysfunction and chronic inflammation in polycystic ovary syndrome. Int J Mol Sci. 22(8):3923.

  22. Zhuo G, Ding Y, Feng G, Yu L, Jiang Y. Analysis of mitochondrial DNA sequence variants in patients with polycystic ovary syndrome. Arch Gynecol Obstet. 2012;286(3):653–9.

    Article  CAS  PubMed  Google Scholar 

  23. Ding Y, Xia BH, Zhang CJ, Zhuo GC. Mutations in mitochondrial tRNA genes may be related to insulin resistance in women with polycystic ovary syndrome. Am J Transl Res. 2017;9(6):2984–96.

    CAS  PubMed  PubMed Central  Google Scholar 

  24. Paul C, Laganà AS, Maniglio P, Triolo O, Brady DM. Inositol’s and other nutraceuticals’ synergistic actions counteract insulin resistance in polycystic ovarian syndrome and metabolic syndrome: state-of-the-art and future perspectives. Gynecol Endocrinol. 2016;32(6):431–8.

    Article  CAS  PubMed  Google Scholar 

  25. Laganà AS, Rossetti P, Buscema M, La Vignera S, Condorelli RA, Gullo G, et al. Metabolism and ovarian function in PCOS women: a therapeutic approach with inositols. Int J Endocrinol. 2016;2016:6306410.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Genazzani AD, Lanzoni C, Ricchieri F, Jasonni VM. Myo-inositol administration positively affects hyperinsulinemia and hormonal parameters in overweight patients with polycystic ovary syndrome. Gynecol Endocrinol. 2008;24(3):139–44.

    Article  CAS  PubMed  Google Scholar 

  27. Esposito K, Marfella R, Ciotola M, Di Palo C, Giugliano F, Giugliano G, et al. Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA. 2004;292(12):1440–6.

    Article  CAS  PubMed  Google Scholar 

  28. Moran LJ, Grieger JA, Mishra GD, Teede HJ. The association of a Mediterranean-style diet pattern with polycystic ovary syndrome status in a community cohort study. Nutrients. 2015;7(10):8553–64.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Boden G, Sargrad K, Homko C, Mozzoli M, Stein TP. Effect of a low-carbohydrate diet on appetite, blood glucose levels, and insulin resistance in obese patients with type 2 diabetes. Ann Intern Med. 2005;142(6):403–11.

    Article  CAS  PubMed  Google Scholar 

  30. Mavropoulos JC, Yancy WS, Hepburn J, Westman EC. The effects of a low-carbohydrate, ketogenic diet on the polycystic ovary syndrome: a pilot study. Nutr Metab (Lond). 2005;2:35.

    Article  PubMed  Google Scholar 

  31. Chiofalo B, Laganà AS, Palmara V, Granese R, Corrado G, Mancini E, et al. Fasting as possible complementary approach for polycystic ovary syndrome: hope or hype? Med Hypotheses. 2017;105:1–3.

    Article  PubMed  Google Scholar 

  32. Muscogiuri G, Palomba S, Laganà AS, Orio F. Current insights into inositol isoforms, Mediterranean and ketogenic diets for polycystic ovary syndrome: from bench to bedside. Curr Pharm Des. 2016;22(36):5554–7.

    Article  CAS  PubMed  Google Scholar 

  33. Rabøl R, Svendsen PF, Skovbro M, Boushel R, Schjerling P, Nilas L, et al. Skeletal muscle mitochondrial function in polycystic ovarian syndrome. Eur J Endocrinol. 2011;165(4):631–7.

    Article  PubMed  Google Scholar 

  34. Ding Y, Zhuo G, Zhang C. The Mitochondrial tRNALeu(UUR) A3302G Mutation may be associated with insulin resistance in woman with polycystic ovary syndrome. Reprod Sci (Thousand Oaks, Calif). 2016;23(2):228–33.

    Article  CAS  Google Scholar 

  35. Siddle K. Signalling by insulin and IGF receptors: supporting acts and new players. J Mol Endocrinol. 2011;47(1):R1-10.

    Article  CAS  PubMed  Google Scholar 

  36. Bahadur A, Verma N, Mundhra R, Chawla L, Ajmani M, Sri MS, et al. Correlation of homeostatic model assessment-insulin resistance, anti-mullerian hormone, and BMI in the characterization of polycystic ovary syndrome. Cureus. 2021;13(6):e16047.

    PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The authors are grateful to the Scientific Research Center in Preventive Medicine, School of Public Health, Anhui Medical University, for the technical support during our experiments.

Funding

This work was supported by the National Key Research and Development Program (2021YFC2700901, 2018YFC1004201), the National Natural Science Foundation of China (NSFC-82173532, NSFC-U20A20350, NSFC-81971455, NSFC-81871216, and NSFC-81803260), the Excellent Young Talents Fund Program of Higher Education Institutions of Anhui Province (gxyq2021173), and the Postdoctoral Research Foundation of China (2021M700181).

Author information

Authors and Affiliations

Authors

Contributions

Shitao He: methodology, formal analysis, data curation, writing – original draft. Dongmei Ji: methodology, formal analysis, visualization, writing – original draft, funding acquisition. Yajing Liu: methodology, investigation. Xiaohong Deng: methodology, formal analysis. Weiwei Zou: methodology, data curation. Dan Liang: methodology, data curation. Yinan Du: methodology. Kai Zong: Methodology. Tingting Jiang: methodology. Mengzhu Li: methodology. Dongyang Zhang: methodology. Xinyu Yue: methodology. Fangbiao Tao: conceptualization, project administration, funding acquisition, resources, supervision, writing – review and editing. Yunxia Cao: conceptualization, funding acquisition, project administration, writing – review and editing. Chunmei Liang: conceptualization, funding acquisition, supervision, writing – review and editing. All authors have read and approved the final version of the manuscript.

Corresponding authors

Correspondence to Fangbiao Tao, Yunxia Cao or Chunmei Liang.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

The original online version of this article was revised: Several mistakes in the main text were missed before this article was published; the authors apologize for any inconvenience caused.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 44 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

He, S., Ji, D., Liu, Y. et al. Polymorphisms of mtDNA in the D-loop region moderate the associations of BMI with HOMA-IR and HOMA-β among women with polycystic ovary syndrome: a cross-sectional study. J Assist Reprod Genet 40, 1983–1993 (2023). https://doi.org/10.1007/s10815-023-02843-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10815-023-02843-7

Keywords

Navigation